A study on the diagnostic value of artificial intelligence combined with a contrast-enhanced ultrasound scoring system in partially cystic thyroid carcinoma

一项关于人工智能联合对比增强超声评分系统在部分囊性甲状腺癌诊断价值的研究

阅读:1

Abstract

OBJECTIVES: The aim of this study was to investigate the diagnostic value of the contrast-enhanced ultrasound (CEUS) scoring system, artificial intelligence (AI) and the American College of Radiology Thyroid Imaging and Reporting Data System when used by sonographers of different seniority levels individually and in combination for the diagnosis of partial cystic thyroid nodules (PCTNs). MATERIALS AND METHODS: A retrospective analysis of conventional ultrasound and CEUS images of enrolled patients was performed, and a CEUS scoring system was established. The sensitivity, specificity, and area under the curve (AUC) of CEUS and AI individually and in combination for diagnosis were compared among sonographers with different seniority levels. RESULTS: A total of 166 nodules (83 benign and 83 malignant) from 152 patients with PCTNs were analyzed in this study. Nine CEUS features of PCTNs were observed and summarized; eight of these features differed between the two groups (all p < 0.05) and were included in the CEUS scoring system. CEUS and AI used by junior and senior physicians effectively diagnosed PCTNs. AI improved the diagnostic efficacy of junior physicians. AI assistance combined with CEUS had the best diagnostic efficacy, with an AUC=0.985 for senior physicians and an AUC=0.967 for junior physicians, with no significant difference (P>0.05). CONCLUSIONS: The CEUS scoring system established in this study has high diagnostic value for PCTNs. The use of CEUS and AI can improve the diagnostic accuracy of sonographers and improve the prognosis of PCTN patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。